天美传媒

ISSN: 2475-3173

Cervical Cancer: 天美传媒 Access
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective   
  • Cervical Cancer 10: 271.,

HPV Progress: Vaccination, Screening, Treatment, Global.

Emily Robertson*
Department of Oncology, University of California, San Francisco, USA
*Corresponding Author : Emily Robertson, Department of Oncology, University of California, San Francisco, USA, Email: emily.robertson@oncologyresearch.edu

Abstract

This collection of 2023 research examines HPV vaccination, screening, prevalence, and treatment. Studies reveal challenges in vaccine uptake, knowledge gaps, and confirm vaccine safety and efficacy. Innovations in HPV DNA methylation and Artificial Intelligence (AI) enhance screening. Research also highlights HPV prevalence globally, its burden in HIV-positive women and men, and evolving treatment strategies for HPV-positive cancers. These findings collectively support global cervical cancer elimination efforts through optimized vaccination and screening programs.

Citation:

Copyright:

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 97
  • [From(publication date): 0-0 - Dec 26, 2025]
  • Breakdown by view type
  • HTML page views: 73
  • PDF downloads: 24
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.